Fundraising FoxFloating Point — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Ataraxis develops AI foundation models that analyze multi-modal patient data, including pathology slide images, to assess cancer aggressiveness and predict recurrence risk and treatment response.
AI & Machine LearningBiotechHealthtechNew York, US
Krzysztof Geras(Chief Scientific Officer & Co-Founder)inJan Witowski(Chief Executive Officer & Co-Founder)in
BoardKrish Ramadural(Director)Rohan Ganeshananthan(Director)
Co-investorsAIX VenturesBlue Trail PartnersGiant Ventures Global LlpObvious VenturesTranspose Platform ManagementBertelsmann Investments+1 more
Dandelion Health develops clinical AI applications by combining healthcare domain expertise with machine learning research to advance AI adoption in healthcare.
AI & Machine LearningDigital HealthHealthtechSyosset, US
Elliott Green(Co-founder and CEO)in
BoardSam Toole(Director)inNiyum Gandhi(Co-founder and Board Chair)inSendhil Mullainathan(Co-founder and Scientific Advisor)inZiad Obermeyer(Co-founder and Chief Scientific Officer)
Co-investorsColle Capital PartnersConvergent VenturesHealthier CapitalMoxxie VenturesPrimary Venture PartnersNew Enterprise Associates (NEA)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.